Sequential cladribine and interferon-alpha (IFN) in chronic myelogenous leukemia (CML).

被引：0
|
作者：
Saven, A
Burian, C
Kosty, M
Mason, J
Douer, D
机构：
[1] Ida M & Cecil H Green Canc Ctr, Div Hematol Oncol, Scripps Clin, La Jolla, CA USA
[2] Univ So Calif, Div Hematol, Norris Canc Ctr, Los Angeles, CA USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4459
引用
收藏
页码：279B / 279B
页数：1
相关论文
共 50 条
  • [21] Use of interferon-alpha (reaferon) in patients with chronic myeloid leukemia (CML)
    Machulaitene, ER
    Lasunskaya, EB
    Nefedova, YB
    Perekalina, TA
    Salogub, GN
    Polyakova, LE
    TERAPEVTICHESKII ARKHIV, 1996, 68 (10) : 44 - 47
  • [22] RANDOMIZED COMPARISON OF INTERFERON-ALPHA WITH BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA
    HEHLMANN, R
    HEIMPEL, H
    HASFORD, J
    KOLB, HJ
    PRALLE, H
    HOSSFELD, DK
    QUEISSER, W
    LOFFLER, H
    HOCHHAUS, A
    HEINZE, B
    GEORGII, A
    BARTRAM, CR
    GRIESSHAMMER, M
    BERGMANN, L
    ESSERS, U
    FALGE, C
    QUEISSER, U
    MEYER, P
    SCHMITZ, N
    EIMERMACHER, H
    WALTHER, F
    FETT, W
    KLEEBERG, UR
    KABISCH, A
    NERL, C
    ZIMMERMANN, R
    MEURET, G
    TICHELLI, A
    KANZ, L
    TIGGES, FJ
    SCHMID, L
    BROCKHAUS, W
    TOBLER, A
    REITER, A
    PERKER, M
    EMMERICH, B
    VERPOORT, K
    ZANKOVICH, R
    VONWUSSOW, P
    PRUMMER, O
    THIELE, J
    BUHR, T
    CARBONELL, F
    ANSARI, H
    BLOOD, 1994, 84 (12) : 4064 - 4077
  • [23] Dysregulation of TAP-1 and TAP-2 gene expression in chronic myelogenous leukemia (CML) - Implications for interferon-alpha (IFN-alpha) responsiveness.
    Berlyn, KA
    Cano, P
    Fan, B
    Lim, JK
    Kantarjian, H
    Talpaz, M
    Mann, DL
    Stass, S
    BLOOD, 1997, 90 (10) : 2302 - 2302
  • [24] Multiple sclerosis associated with interferon-alpha therapy for chronic myelogenous leukemia
    Kataoka, I
    Shinagawa, K
    Shiro, Y
    Okamoto, S
    Watanabe, R
    Mori, T
    Ito, D
    Harada, M
    AMERICAN JOURNAL OF HEMATOLOGY, 2002, 70 (02) : 149 - 153
  • [25] Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia
    Wilhelm, M
    Bueso-Ramos, C
    O'Brien, S
    Pierce, S
    Keating, M
    Talpaz, M
    Kantarjian, HM
    LEUKEMIA, 1998, 12 (01) : 65 - 70
  • [26] ACUTE-PANCREATITIS ASSOCIATED WITH INTERFERON-ALPHA THERAPY FOR CHRONIC MYELOGENOUS LEUKEMIA
    SOTOMATSU, M
    SHIMODA, M
    OGAWA, C
    MORIKAWA, A
    AMERICAN JOURNAL OF HEMATOLOGY, 1995, 48 (03) : 211 - 212
  • [27] Effect of interferon-alpha therapy on bone marrow fibrosis in chronic myelogenous leukemia
    M Wilhelm
    C Bueso-Ramos
    S O’Brien
    S Pierce
    M Keating
    M Talpaz
    HM Kantarjian
    Leukemia, 1998, 12 : 65 - 70
  • [28] PROGNOSTIC FACTORS FOR RESPONSE AND SURVIVAL WITH ALPHA-INTERFERON (IFN-A) THERAPY IN EARLY CHRONIC PHASE CHRONIC MYELOGENOUS LEUKEMIA (CML)
    KANTARJIAN, H
    SMITH, T
    OBRIEN, S
    ROBERTSON, L
    KOLLER, C
    BERAN, M
    KEATING, M
    TALPAZ, M
    BLOOD, 1993, 82 (10) : A378 - A378
  • [29] Early treatment decisions with interferon alpha (IFN-A) therapy in early chronic phase chronic myelogenous leukemia (CP-CML).
    Sacchi, S
    Kantarjian, K
    Smith, T
    OBrien, S
    Pierce, S
    Kornblau, S
    Beran, M
    Keating, M
    Talpaz, M
    BLOOD, 1997, 90 (10) : 2303 - 2303
  • [30] Association of HLA phenotype and response to interferon-alpha in patients with chronic myelogenous leukemia
    J Cortes
    L Fayad
    H Kantarjian
    S O’Brien
    M-S Lee
    M Talpaz
    Leukemia, 1998, 12 : 455 - 462
12345